Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Calumet Specialty Products Partners, L.P.CLMT · Entity 91042 | Director | May 07, 2024 | May 09, 2024 |
| Calumet, Inc. /DECLMT · Entity 3988 | Director | June 09, 2025 | June 12, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Calumet Specialty Products Partners, L.P.
Report date May 07, 2024 · Filed May 09, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Phantom UnitSEC Table II · derivative / convertible security | Direct | 1,594 |
Reported balance
After 2024-05-07 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2024-05-07 · Grant · Acquired 1,594 · Balance 1,594 F1: Each Phantom Unit is the economic equivalent of a Calumet Specialty Products Partners, L.P. Common Unit. F2: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date. Phantom Units are 100% vested. |
| Phantom UnitsSEC Table II · derivative / convertible security | Direct | 531 |
Reported balance
After 2024-05-07 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2024-05-07 · Grant · Acquired 531 · Balance 531 F1: Each Phantom Unit is the economic equivalent of a Calumet Specialty Products Partners, L.P. Common Unit. F3: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date pursuant to the Deferred Compensation Plan. 25% of the Phantom Units vest on July 1 of each year beginning on July 1, 2025. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Phantom Unit is the economic equivalent of a Calumet Specialty Products Partners, L.P. Common Unit.
F2: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date. Phantom Units are 100% vested.
F3: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date pursuant to the Deferred Compensation Plan. 25% of the Phantom Units vest on July 1 of each year beginning on July 1, 2025.
Calumet, Inc. /DE
Report date June 09, 2025 · Filed June 12, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 3,796 |
Reported balance
After 2025-06-09 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-06-09 · Grant · Acquired 3,796 · Balance 3,796 F1: Each Restricted Stock Unit is the economic equivalent of one share of Calumet, Inc. common stock, par value $0.01 per share. F2: Restricted Stock Units are 100% vested. Restricted Stock Units will be settled upon vesting. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Restricted Stock Unit is the economic equivalent of one share of Calumet, Inc. common stock, par value $0.01 per share.
F2: Restricted Stock Units are 100% vested. Restricted Stock Units will be settled upon vesting.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 22, 2022 Filed Feb 24, 2022 17:56 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | GrantPhantom Units · Derivative | 1,604 | $0.00 | $0.00 |
DisclosureSEC source: 0001340122-22-000020 · wf-form4_164574338350324.xml · derivative · entry 1 Carter James S · CIK 0001351915 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,604 Underlying: Common Units · 1,604 shares Expires not disclosed F1 · derivative.exercise_price: Each Phantom Unit is the economic equivalent of a Calumet Specialty Products Partners, L.P. Common Unit. F2 · derivative.exercise_date: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date. Phantom Units are 100% vested. F2 · derivative.expiration_date: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date. Phantom Units are 100% vested. Read SEC document |
| November 03, 2021 Filed Nov 5, 2021 20:44 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | GrantPhantom Units · Derivative | 8,921 | $0.00 | $0.00 |
DisclosureSEC source: 0001340122-21-000102 · wf-form4_163615944936610.xml · derivative · entry 3 Carter James S · CIK 0001351915 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,921 Underlying: Common Units · 8,921 shares Expires not disclosed F1 · derivative.exercise_price: Each Phantom Unit is the economic equivalent of a Calumet Specialty Products Partners, L.P. Common Unit. F4 · derivative.exercise_date: Phantom Units vest on December 31, 2023. Phantom Units will be settled upon vesting. F4 · derivative.expiration_date: Phantom Units vest on December 31, 2023. Phantom Units will be settled upon vesting. Read SEC document |
| November 03, 2021 Filed Nov 5, 2021 20:44 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | GrantPhantom Units · Derivative | 699 | $0.00 | $0.00 |
DisclosureSEC source: 0001340122-21-000102 · wf-form4_163615944936610.xml · derivative · entry 2 Carter James S · CIK 0001351915 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 699 Underlying: Common Units · 699 shares Expires not disclosed F1 · derivative.exercise_price: Each Phantom Unit is the economic equivalent of a Calumet Specialty Products Partners, L.P. Common Unit. F3 · derivative.exercise_date: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date pursuant to the Deferred Compensation Plan. 25% of the Phantom Units vest on July 1 of each year beginning on July 1, 2022. F3 · derivative.expiration_date: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date pursuant to the Deferred Compensation Plan. 25% of the Phantom Units vest on July 1 of each year beginning on July 1, 2022. Read SEC document |
| November 03, 2021 Filed Nov 5, 2021 20:44 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | GrantPhantom Units · Derivative | 2,096 | $0.00 | $0.00 |
DisclosureSEC source: 0001340122-21-000102 · wf-form4_163615944936610.xml · derivative · entry 1 Carter James S · CIK 0001351915 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,096 Underlying: Common Units · 2,096 shares Expires not disclosed F1 · derivative.exercise_price: Each Phantom Unit is the economic equivalent of a Calumet Specialty Products Partners, L.P. Common Unit. F2 · derivative.exercise_date: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date. Phantom Units are 100% vested. F2 · derivative.expiration_date: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date. Phantom Units are 100% vested. Read SEC document |
| August 03, 2021 Filed Aug 5, 2021 16:53 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | GrantPhantom Units · Derivative | 1,166 | $0.00 | $0.00 |
DisclosureSEC source: 0001340122-21-000081 · wf-form4_162819667849436.xml · derivative · entry 2 Carter James S · CIK 0001351915 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,166 Underlying: Common Units · 1,166 shares Expires not disclosed F1 · derivative.exercise_price: Each Phantom Unit is the economic equivalent of a Calumet Specialty Products Partners, L.P. Common Unit. F3 · derivative.exercise_date: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date pursuant to the Deferred Compensation Plan. 25% of the Phantom Units vest on July 1 of each year beginning on July 1, 2022. F3 · derivative.expiration_date: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date pursuant to the Deferred Compensation Plan. 25% of the Phantom Units vest on July 1 of each year beginning on July 1, 2022. Read SEC document |
| August 03, 2021 Filed Aug 5, 2021 16:53 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | GrantPhantom Units · Derivative | 3,497 | $0.00 | $0.00 |
DisclosureSEC source: 0001340122-21-000081 · wf-form4_162819667849436.xml · derivative · entry 1 Carter James S · CIK 0001351915 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,497 Underlying: Common Units · 3,497 shares Expires not disclosed F1 · derivative.exercise_price: Each Phantom Unit is the economic equivalent of a Calumet Specialty Products Partners, L.P. Common Unit. F2 · derivative.exercise_date: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date. Phantom Units are 100% vested. F2 · derivative.expiration_date: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date. Phantom Units are 100% vested. Read SEC document |
| May 05, 2021 Filed May 7, 2021 14:56 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | GrantPhantom Units · Derivative | 1,253 | $0.00 | $0.00 |
DisclosureSEC source: 0001340122-21-000066 · wf-form4_162041367363055.xml · derivative · entry 2 Carter James S · CIK 0001351915 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,253 Underlying: Common Units · 1,253 shares Expires not disclosed F1 · derivative.exercise_price: Each Phantom Unit is the economic equivalent of a Calumet Specialty Products Partners, L.P. Common Unit. F3 · derivative.exercise_date: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date pursuant to the Deferred Compensation Plan. 25% of the Phantom Units vest on July 1 of each year beginning on July 1, 2022. F3 · derivative.expiration_date: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date pursuant to the Deferred Compensation Plan. 25% of the Phantom Units vest on July 1 of each year beginning on July 1, 2022. Read SEC document |
| May 05, 2021 Filed May 7, 2021 14:56 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | GrantPhantom Units · Derivative | 3,760 | $0.00 | $0.00 |
DisclosureSEC source: 0001340122-21-000066 · wf-form4_162041367363055.xml · derivative · entry 1 Carter James S · CIK 0001351915 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,760 Underlying: Common Units · 3,760 shares Expires not disclosed F1 · derivative.exercise_price: Each Phantom Unit is the economic equivalent of a Calumet Specialty Products Partners, L.P. Common Unit. F2 · derivative.exercise_date: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date. Phantom Units are 100% vested. F2 · derivative.expiration_date: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date. Phantom Units are 100% vested. Read SEC document |
| March 23, 2021 Filed Mar 24, 2021 17:33 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | Exercise / conversionPhantom Units · Derivative | 45 | $0.00 | $0.00 |
DisclosureSEC source: 0001340122-21-000053 · wf-form4_161662160118853.xml · derivative · entry 2 Carter James S · CIK 0001351915 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Units · 45 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Phantom Unit is the economic equivalent of a Calumet Specialty Products Partners, L.P. Common Unit. F2 · derivative.exercise_date: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date pursuant to the Deferred Compensation Plan. 25% of the Phantom Units vest on July 1 of each year beginning on July 1, 2016. F2 · derivative.expiration_date: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date pursuant to the Deferred Compensation Plan. 25% of the Phantom Units vest on July 1 of each year beginning on July 1, 2016. Read SEC document |
| March 23, 2021 Filed Mar 24, 2021 17:33 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | Exercise / conversionCommon Units | 45 | $0.00 | $0.00 |
DisclosureSEC source: 0001340122-21-000053 · wf-form4_161662160118853.xml · nonDerivative · entry 1 Carter James S · CIK 0001351915 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 274,180 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 03, 2021 Filed Mar 4, 2021 17:51 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | Exercise / conversionPhantom Units · Derivative | 7,102 | $0.00 | $0.00 |
DisclosureSEC source: 0001340122-21-000037 · wf-form4_161489825770831.xml · derivative · entry 10 Carter James S · CIK 0001351915 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,103 Underlying: Common Units · 7,102 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Phantom Unit is the economic equivalent of a Calumet Specialty Products Partners, L.P. Common Unit. F6 · derivative.exercise_date: 25% of the Phantom Units vested immediately and the remaining vest ratably over three years on December 31 of each year beginning on December 31, 2019. F6 · derivative.expiration_date: 25% of the Phantom Units vested immediately and the remaining vest ratably over three years on December 31 of each year beginning on December 31, 2019. Read SEC document |
| March 03, 2021 Filed Mar 4, 2021 17:51 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | Exercise / conversionPhantom Units · Derivative | 48,669 | $0.00 | $0.00 |
DisclosureSEC source: 0001340122-21-000037 · wf-form4_161489825770831.xml · derivative · entry 9 Carter James S · CIK 0001351915 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Units · 48,669 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Phantom Unit is the economic equivalent of a Calumet Specialty Products Partners, L.P. Common Unit. F5 · derivative.exercise_date: 100% of the Phantom Units vest on December 31, 2020. F5 · derivative.expiration_date: 100% of the Phantom Units vest on December 31, 2020. Read SEC document |
| March 03, 2021 Filed Mar 4, 2021 17:51 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | Exercise / conversionPhantom Units · Derivative | 7,882 | $0.00 | $0.00 |
DisclosureSEC source: 0001340122-21-000037 · wf-form4_161489825770831.xml · derivative · entry 8 Carter James S · CIK 0001351915 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Units · 7,882 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Phantom Unit is the economic equivalent of a Calumet Specialty Products Partners, L.P. Common Unit. F4 · derivative.exercise_date: 25% of the Phantom Units vested immediately and the remaining vest ratably over three years on December 31 of each year beginning on December 31, 2018. F4 · derivative.expiration_date: 25% of the Phantom Units vested immediately and the remaining vest ratably over three years on December 31 of each year beginning on December 31, 2018. Read SEC document |
| March 03, 2021 Filed Mar 4, 2021 17:51 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | Exercise / conversionPhantom Units · Derivative | 21,090 | $0.00 | $0.00 |
DisclosureSEC source: 0001340122-21-000037 · wf-form4_161489825770831.xml · derivative · entry 7 Carter James S · CIK 0001351915 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Units · 21,090 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Phantom Unit is the economic equivalent of a Calumet Specialty Products Partners, L.P. Common Unit. F3 · derivative.exercise_date: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date pursuant to the Deferred Compensation Plan. Phantom Units are 100% vested. F3 · derivative.expiration_date: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date pursuant to the Deferred Compensation Plan. Phantom Units are 100% vested. Read SEC document |
| March 03, 2021 Filed Mar 4, 2021 17:51 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | Exercise / conversionPhantom Units · Derivative | 6,595 | $0.00 | $0.00 |
DisclosureSEC source: 0001340122-21-000037 · wf-form4_161489825770831.xml · derivative · entry 6 Carter James S · CIK 0001351915 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Units · 6,595 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Phantom Unit is the economic equivalent of a Calumet Specialty Products Partners, L.P. Common Unit. F2 · derivative.exercise_date: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date pursuant to the Deferred Compensation Plan. 25% of the Phantom Units vest on July 1 of each year beginning on July 1, 2017. F2 · derivative.expiration_date: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date pursuant to the Deferred Compensation Plan. 25% of the Phantom Units vest on July 1 of each year beginning on July 1, 2017. Read SEC document |
| March 03, 2021 Filed Mar 4, 2021 17:51 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | Exercise / conversionCommon Units | 7,102 | $0.00 | $0.00 |
DisclosureSEC source: 0001340122-21-000037 · wf-form4_161489825770831.xml · nonDerivative · entry 5 Carter James S · CIK 0001351915 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 274,135 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 03, 2021 Filed Mar 4, 2021 17:51 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | Exercise / conversionCommon Units | 48,669 | $0.00 | $0.00 |
DisclosureSEC source: 0001340122-21-000037 · wf-form4_161489825770831.xml · nonDerivative · entry 4 Carter James S · CIK 0001351915 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 267,033 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 03, 2021 Filed Mar 4, 2021 17:51 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | Exercise / conversionCommon Units | 7,882 | $0.00 | $0.00 |
DisclosureSEC source: 0001340122-21-000037 · wf-form4_161489825770831.xml · nonDerivative · entry 3 Carter James S · CIK 0001351915 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 218,364 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 03, 2021 Filed Mar 4, 2021 17:51 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | Exercise / conversionCommon Units | 21,090 | $0.00 | $0.00 |
DisclosureSEC source: 0001340122-21-000037 · wf-form4_161489825770831.xml · nonDerivative · entry 2 Carter James S · CIK 0001351915 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 210,482 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 03, 2021 Filed Mar 4, 2021 17:51 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | Exercise / conversionCommon Units | 6,595 | $0.00 | $0.00 |
DisclosureSEC source: 0001340122-21-000037 · wf-form4_161489825770831.xml · nonDerivative · entry 1 Carter James S · CIK 0001351915 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 189,392 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 19:51 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | GrantPhantom Units · Derivative | 1,968 | $0.00 | $0.00 |
DisclosureSEC source: 0001340122-21-000017 · wf-form4_161430069540056.xml · derivative · entry 2 Carter James S · CIK 0001351915 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,968 Underlying: Common Units · 1,968 shares Expires not disclosed F1 · derivative.exercise_price: Each Phantom Unit is the economic equivalent of a Calumet Specialty Products Partners, L.P. Common Unit. F3 · derivative.exercise_date: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date pursuant to the Deferred Compensation Plan. 25% of the Phantom Units vest on July 1 of each year beginning on July 1, 2022. F3 · derivative.expiration_date: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date pursuant to the Deferred Compensation Plan. 25% of the Phantom Units vest on July 1 of each year beginning on July 1, 2022. Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 19:51 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | GrantPhantom Unit · Derivative | 5,905 | $0.00 | $0.00 |
DisclosureSEC source: 0001340122-21-000017 · wf-form4_161430069540056.xml · derivative · entry 1 Carter James S · CIK 0001351915 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,905 Underlying: Common Units · 5,905 shares Expires not disclosed F1 · derivative.exercise_price: Each Phantom Unit is the economic equivalent of a Calumet Specialty Products Partners, L.P. Common Unit. F2 · derivative.exercise_date: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date. Phantom Units are 100% vested. F2 · derivative.expiration_date: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date. Phantom Units are 100% vested. Read SEC document |
| November 03, 2020 Filed Nov 5, 2020 20:01 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | GrantPhantom Units · Derivative | 27,855 | $0.00 | $0.00 |
DisclosureSEC source: 0001340122-20-000112 · wf-form4_160462448762442.xml · derivative · entry 1 Carter James S · CIK 0001351915 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,855 Underlying: Common Units · 27,855 shares Expires not disclosed F1 · derivative.exercise_price: Each Phantom Unit is the economic equivalent of a Calumet Specialty Products Partners, L.P. Common Unit. F2 · derivative.exercise_date: Phantom Units vest on December 31, 2022. Phantom Units will be settled upon vesting. F2 · derivative.expiration_date: Phantom Units vest on December 31, 2022. Phantom Units will be settled upon vesting. Read SEC document |
| November 03, 2020 Filed Nov 5, 2020 17:50 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | GrantPhantom Units · Derivative | 6,546 | $3.59 | $23,500.14 |
DisclosureSEC source: 0001340122-20-000108 · wf-form4_160461663015487.xml · derivative · entry 2 Carter James S · CIK 0001351915 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,602 Underlying: Common Units · 6,546 shares Expires not disclosed F1 · derivative.exercise_price: Each Phantom Unit is the economic equivalent of a Calumet Specialty Products Partners, L.P. Common Unit. F3 · derivative.exercise_date: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date. Phantom Units are 100% vested. F3 · derivative.expiration_date: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date. Phantom Units are 100% vested. Read SEC document |
| November 03, 2020 Filed Nov 5, 2020 17:50 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | GrantPhantom Unit · Derivative | 2,182 | $3.59 | $7,833.38 |
DisclosureSEC source: 0001340122-20-000108 · wf-form4_160461663015487.xml · derivative · entry 1 Carter James S · CIK 0001351915 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,463 Underlying: Common Unit · 2,182 shares Expires not disclosed F1 · derivative.exercise_price: Each Phantom Unit is the economic equivalent of a Calumet Specialty Products Partners, L.P. Common Unit. F2 · derivative.exercise_date: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date pursuant to the Deferred Compensation Plan. 25% of the Phantom Units vest on July 1 of each year beginning on July 1, 2021. F2 · derivative.expiration_date: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date pursuant to the Deferred Compensation Plan. 25% of the Phantom Units vest on July 1 of each year beginning on July 1, 2021. Read SEC document |
| October 22, 2020 Filed Oct 23, 2020 15:29 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | Exercise / conversionPhantom Unit · Derivative | 90 | $0.00 | $0.00 |
DisclosureSEC source: 0001340122-20-000100 · wf-form4_160348135504750.xml · derivative · entry 2 Carter James S · CIK 0001351915 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,281 Underlying: Common Unit · 90 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Phantom Unit is the economic equivalent of a Calumet Specialty Products Partners, L.P. Common Unit. F2 · derivative.exercise_date: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination ofservice.25% of the Phantom Units vest on July 1 of each year beginning on July 1, 2017. F2 · derivative.expiration_date: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination ofservice.25% of the Phantom Units vest on July 1 of each year beginning on July 1, 2017. Read SEC document |
| October 22, 2020 Filed Oct 23, 2020 15:29 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | Exercise / conversionCommon Units | 90 | $0.00 | $0.00 |
DisclosureSEC source: 0001340122-20-000100 · wf-form4_160348135504750.xml · nonDerivative · entry 1 Carter James S · CIK 0001351915 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 182,797 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 31, 2020 Filed Aug 4, 2020 17:06 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | GrantPhantom Units · Derivative | 9,004 | $2.61 | $23,500.44 |
DisclosureSEC source: 0001340122-20-000081 · wf-form4_159657501482813.xml · derivative · entry 2 Carter James S · CIK 0001351915 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,056 Underlying: Common Units · 9,004 shares Expires not disclosed F1 · derivative.exercise_price: Each Phantom Unit is the economic equivalent of a Calumet Specialty Products Partners, L.P. Common Unit. F3 · derivative.exercise_date: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date. Phantom Units are 100% vested. F3 · derivative.expiration_date: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date. Phantom Units are 100% vested. Read SEC document |
| July 31, 2020 Filed Aug 4, 2020 17:06 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | GrantPhantom Unit · Derivative | 3,001 | $2.61 | $7,832.61 |
DisclosureSEC source: 0001340122-20-000081 · wf-form4_159657501482813.xml · derivative · entry 1 Carter James S · CIK 0001351915 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,371 Underlying: Common Unit · 3,001 shares Expires not disclosed F1 · derivative.exercise_price: Each Phantom Unit is the economic equivalent of a Calumet Specialty Products Partners, L.P. Common Unit. F2 · derivative.exercise_date: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date pursuant to the Deferred Compensation Plan. 25% of the Phantom Units vest on July 1 of each year beginning on July 1, 2021. F2 · derivative.expiration_date: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date pursuant to the Deferred Compensation Plan. 25% of the Phantom Units vest on July 1 of each year beginning on July 1, 2021. Read SEC document |
| May 19, 2020 Filed May 27, 2020 15:55 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | GrantPhantom Units · Derivative | 9,792 | $2.40 | $23,500.80 |
DisclosureSEC source: 0001340122-20-000073 · wf-form4_159060929242250.xml · derivative · entry 2 Carter James S · CIK 0001351915 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,052 Underlying: Common Units · 9,792 shares Expires not disclosed F1 · derivative.exercise_price: Each Phantom Unit is the economic equivalent of a Calumet Specialty Products Partners, L.P. Common Unit. F3 · derivative.exercise_date: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date. Phantom Units are 100% vested. F3 · derivative.expiration_date: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date. Phantom Units are 100% vested. Read SEC document |
| May 19, 2020 Filed May 27, 2020 15:55 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | GrantPhantom Unit · Derivative | 3,264 | $2.40 | $7,833.60 |
DisclosureSEC source: 0001340122-20-000073 · wf-form4_159060929242250.xml · derivative · entry 1 Carter James S · CIK 0001351915 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,370 Underlying: Common Unit · 3,264 shares Expires not disclosed F1 · derivative.exercise_price: Each Phantom Unit is the economic equivalent of a Calumet Specialty Products Partners, L.P. Common Unit. F2 · derivative.exercise_date: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date pursuant to the Deferred Compensation Plan. 25% of the Phantom Units vest on July 1 of each year beginning on July 1, 2021. F2 · derivative.expiration_date: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date pursuant to the Deferred Compensation Plan. 25% of the Phantom Units vest on July 1 of each year beginning on July 1, 2021. Read SEC document |
| March 24, 2020 Filed Mar 24, 2020 17:52 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | Exercise / conversionPhantom Units · Derivative | 14,204 | $0.00 | $0.00 |
DisclosureSEC source: 0001340122-20-000056 · wf-form4_158508674227234.xml · derivative · entry 2 Carter James S · CIK 0001351915 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,205 Underlying: Common Units · 14,204 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Phantom Unit is the economic equivalent of a Calumet Specialty Products Partners, L.P. Common Unit. F2 · derivative.exercise_date: 25% of the Phantom Units vested immediately and the remaining vest ratably over three years on December 31 of each year beginning on December 31, 2019. Phantom units will be settled upon vesting. F2 · derivative.expiration_date: 25% of the Phantom Units vested immediately and the remaining vest ratably over three years on December 31 of each year beginning on December 31, 2019. Phantom units will be settled upon vesting. Read SEC document |
| March 24, 2020 Filed Mar 24, 2020 17:52 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | Exercise / conversionCommon Units | 14,204 | $0.00 | $0.00 |
DisclosureSEC source: 0001340122-20-000056 · wf-form4_158508674227234.xml · nonDerivative · entry 1 Carter James S · CIK 0001351915 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 182,707 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 27, 2020 Filed Mar 2, 2020 21:01 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | GrantPhantom Unit · Derivative | 0 | $3.72 | $0.00 |
DisclosureSEC source: 0001340122-20-000023 · wf-form4_158320085320334.xml · derivative · entry 12 Carter James S · CIK 0001351915 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,106 Underlying: Common Unit · 2,106 shares Expires not disclosed F1 · derivative.exercise_price: Each Phantom Unit is the economic equivalent of a Calumet Specialty Products Partners, L.P. Common Unit. F7 · derivative.exercise_date: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date pursuant to the Deferred Compensation Plan. 25% of the Phantom Units vest on July 1 of each year beginning on July 1, 2021. F7 · derivative.expiration_date: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date pursuant to the Deferred Compensation Plan. 25% of the Phantom Units vest on July 1 of each year beginning on July 1, 2021. Read SEC document |
| February 27, 2020 Filed Mar 2, 2020 21:01 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | GrantPhantom Units · Derivative | 0 | $3.72 | $0.00 |
DisclosureSEC source: 0001340122-20-000023 · wf-form4_158320085320334.xml · derivative · entry 11 Carter James S · CIK 0001351915 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,260 Underlying: Common Units · 6,317 shares Expires not disclosed F1 · derivative.exercise_price: Each Phantom Unit is the economic equivalent of a Calumet Specialty Products Partners, L.P. Common Unit. F6 · derivative.exercise_date: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date. Phantom Units are 100% vested. F6 · derivative.expiration_date: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date. Phantom Units are 100% vested. Read SEC document |
| February 27, 2020 Filed Mar 2, 2020 21:01 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | Exercise / conversionPhantom Unit · Derivative | 901 | $0.00 | $0.00 |
DisclosureSEC source: 0001340122-20-000023 · wf-form4_158320085320334.xml · derivative · entry 10 Carter James S · CIK 0001351915 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,189 Underlying: Common Units · 901 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Phantom Unit is the economic equivalent of a Calumet Specialty Products Partners, L.P. Common Unit. F5 · derivative.exercise_date: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date pursuant to the Deferred Compensation Plan. 25% of the Phantom Units vest on July 1 of each year beginning on July 1, 2016. F5 · derivative.expiration_date: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date pursuant to the Deferred Compensation Plan. 25% of the Phantom Units vest on July 1 of each year beginning on July 1, 2016. Read SEC document |
| February 27, 2020 Filed Mar 2, 2020 21:01 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | Exercise / conversionPhantom Units · Derivative | 2,977 | $0.00 | $0.00 |
DisclosureSEC source: 0001340122-20-000023 · wf-form4_158320085320334.xml · derivative · entry 9 Carter James S · CIK 0001351915 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,943 Underlying: Common Units · 2,977 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Phantom Unit is the economic equivalent of a Calumet Specialty Products Partners, L.P. Common Unit. F4 · derivative.exercise_date: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date pursuant to the Deferred Compensation Plan. Phantom Units are 100% vested. F4 · derivative.expiration_date: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date pursuant to the Deferred Compensation Plan. Phantom Units are 100% vested. Read SEC document |
| February 27, 2020 Filed Mar 2, 2020 21:01 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | Exercise / conversionPhantom Units · Derivative | 7,935 | $0.00 | $0.00 |
DisclosureSEC source: 0001340122-20-000023 · wf-form4_158320085320334.xml · derivative · entry 8 Carter James S · CIK 0001351915 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Units · 7,935 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Phantom Unit is the economic equivalent of a Calumet Specialty Products Partners, L.P. Common Unit. F3 · derivative.exercise_date: 25% of the Phantom Units vest on December 31 of each year beginning on December 31, 2016. F3 · derivative.expiration_date: 25% of the Phantom Units vest on December 31 of each year beginning on December 31, 2016. Read SEC document |
| February 27, 2020 Filed Mar 2, 2020 21:01 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | Exercise / conversionPhantom Units · Derivative | 2,674 | $0.00 | $0.00 |
DisclosureSEC source: 0001340122-20-000023 · wf-form4_158320085320334.xml · derivative · entry 7 Carter James S · CIK 0001351915 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,673 Underlying: Common Units · 2,674 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Phantom Unit is the economic equivalent of a Calumet Specialty Products Partners, L.P. Common Unit. F2 · derivative.exercise_date: 25% of the Phantom Units vested immediately and the remaining vest ratably over three years on December 31 of each year beginning on December 31, 2018. F2 · derivative.expiration_date: 25% of the Phantom Units vested immediately and the remaining vest ratably over three years on December 31 of each year beginning on December 31, 2018. Read SEC document |
| February 27, 2020 Filed Mar 2, 2020 21:01 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | Exercise / conversionPhantom Units · Derivative | 5,208 | $0.00 | $0.00 |
DisclosureSEC source: 0001340122-20-000023 · wf-form4_158320085320334.xml · derivative · entry 6 Carter James S · CIK 0001351915 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,209 Underlying: Common Unit · 5,208 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Phantom Unit is the economic equivalent of a Calumet Specialty Products Partners, L.P. Common Unit. F2 · derivative.exercise_date: 25% of the Phantom Units vested immediately and the remaining vest ratably over three years on December 31 of each year beginning on December 31, 2018. F2 · derivative.expiration_date: 25% of the Phantom Units vested immediately and the remaining vest ratably over three years on December 31 of each year beginning on December 31, 2018. Read SEC document |
| February 27, 2020 Filed Mar 2, 2020 21:01 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | Exercise / conversionCommon Units | 901 | $0.00 | $0.00 |
DisclosureSEC source: 0001340122-20-000023 · wf-form4_158320085320334.xml · nonDerivative · entry 5 Carter James S · CIK 0001351915 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168,503 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 27, 2020 Filed Mar 2, 2020 21:01 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | Exercise / conversionCommon Units | 2,977 | $0.00 | $0.00 |
DisclosureSEC source: 0001340122-20-000023 · wf-form4_158320085320334.xml · nonDerivative · entry 4 Carter James S · CIK 0001351915 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 167,602 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 27, 2020 Filed Mar 2, 2020 21:01 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | Exercise / conversionCommon Units | 7,935 | $0.00 | $0.00 |
DisclosureSEC source: 0001340122-20-000023 · wf-form4_158320085320334.xml · nonDerivative · entry 3 Carter James S · CIK 0001351915 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164,625 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 27, 2020 Filed Mar 2, 2020 21:01 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | Exercise / conversionCommon Units | 2,674 | $0.00 | $0.00 |
DisclosureSEC source: 0001340122-20-000023 · wf-form4_158320085320334.xml · nonDerivative · entry 2 Carter James S · CIK 0001351915 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,690 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 27, 2020 Filed Mar 2, 2020 21:01 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | Exercise / conversionCommon Units | 5,208 | $0.00 | $0.00 |
DisclosureSEC source: 0001340122-20-000023 · wf-form4_158320085320334.xml · nonDerivative · entry 1 Carter James S · CIK 0001351915 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,016 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 06, 2019 Filed Mar 11, 2020 11:51 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | GrantPhantom Units · Derivative | 28,409 | $0.00 | $0.00 |
DisclosureSEC source: 0001340122-20-000043 · wf-form4_158394186370012.xml · derivative · entry 1 Carter James S · CIK 0001351915 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,409 Underlying: Common Units · 28,409 shares Expires not disclosed F1 · derivative.exercise_price: Each Phantom Unit is the economic equivalent of a Calumet Specialty Products Partners, L.P. Common Unit. F2 · derivative.exercise_date: 25% of the Phantom Units vested immediately and the remaining vest ratably over three years on December 31 of each year beginning on December 31, 2019. Phantom units will be settled upon vesting. F2 · derivative.expiration_date: 25% of the Phantom Units vested immediately and the remaining vest ratably over three years on December 31 of each year beginning on December 31, 2019. Phantom units will be settled upon vesting. Read SEC document |
| November 04, 2019 Filed Nov 6, 2019 17:30 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | GrantPhantom Unit · Derivative | 0 | $3.47 | $0.00 |
DisclosureSEC source: 0001340122-19-000117 · wf-form4_157307941861524.xml · derivative · entry 2 Carter James S · CIK 0001351915 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,090 Underlying: Common Units · 2,257 shares Expires not disclosed F1 · derivative.exercise_price: Each Phantom Unit is the economic equivalent of a Calumet Specialty Products Partners, L.P. Common Unit. F3 · derivative.exercise_date: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date pursuant to the Deferred Compensation Plan. 25% of the Phantom Units vest on July 1 of each year beginning on July 1, 2020. F3 · derivative.expiration_date: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date pursuant to the Deferred Compensation Plan. 25% of the Phantom Units vest on July 1 of each year beginning on July 1, 2020. Read SEC document |
| November 04, 2019 Filed Nov 6, 2019 17:30 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | GrantPhantom Units · Derivative | 0 | $3.47 | $0.00 |
DisclosureSEC source: 0001340122-19-000117 · wf-form4_157307941861524.xml · derivative · entry 1 Carter James S · CIK 0001351915 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,920 Underlying: Common Units · 6,772 shares Expires not disclosed F1 · derivative.exercise_price: Each Phantom Unit is the economic equivalent of a Calumet Specialty Products Partners, L.P. Common Unit. F2 · derivative.exercise_date: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date. Phantom Units are 100% vested. F2 · derivative.expiration_date: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date. Phantom Units are 100% vested. Read SEC document |
| August 06, 2019 Filed Aug 8, 2019 15:47 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | GrantPhantom Unit · Derivative | 1,663 | $4.71 | $7,832.73 |
DisclosureSEC source: 0001340122-19-000086 · wf-form4_156529364961024.xml · derivative · entry 2 Carter James S · CIK 0001351915 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,833 Underlying: Common Units · 1,663 shares Expires not disclosed F1 · derivative.exercise_price: Each Phantom Unit is the economic equivalent of a Calumet Specialty Products Partners, L.P. Common Unit. F3 · derivative.exercise_date: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date pursuant to the Deferred Compensation Plan. 25% of the Phantom Units vest on July 1 of each year beginning on July 1, 2020. F3 · derivative.expiration_date: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date pursuant to the Deferred Compensation Plan. 25% of the Phantom Units vest on July 1 of each year beginning on July 1, 2020. Read SEC document |
| August 06, 2019 Filed Aug 8, 2019 15:47 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | GrantPhantom Units · Derivative | 4,989 | $4.71 | $23,498.19 |
DisclosureSEC source: 0001340122-19-000086 · wf-form4_156529364961024.xml · derivative · entry 1 Carter James S · CIK 0001351915 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,148 Underlying: Common Units · 4,989 shares Expires not disclosed F1 · derivative.exercise_price: Each Phantom Unit is the economic equivalent of a Calumet Specialty Products Partners, L.P. Common Unit. F2 · derivative.exercise_date: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date. Phantom Units are 100% vested. F2 · derivative.expiration_date: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date. Phantom Units are 100% vested. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.